Skip to ContentSkip to Footer
6 issues for free
Subscribe
Subscribe
6 issues for free6 issues for free
Analysis

What the market reaction to the Covid vaccine news tells us about the “new normal”

Stockmarkets are soaring on news that Pfizer’s Covid vaccine could be much more effective than expected. It’s not all unbridled joy, however, and safe haven assets in particular have taken a hit. John Stepek looks at what it all means.

by: John Stepek
9 Nov 2020
Pfizer HQ

News from Pfizer has given the markets a shot in the arm

© KENA BETANCUR/AFP via Getty Images

To continue reading and get instant access to more investment news for free, please register below

We will use the details you have shared to manage your registration. You agree to the processing, storage, sharing and use of this information for the purpose of managing your registration as described in our Privacy Policy.

We will use the details you have shared to manage your newsletter subscription. You agree to the processing, storage, sharing and use of this information for the purpose of managing your subscription as described in our Privacy Policy.

We will use the information you have shared for carefully considered and specific purposes, where we believe we have a legitimate case to do so, for example to send you communications about similar products and services we offer. You can find out more about our legitimate interest activity in our Privacy Policy.

'We' includes MoneyWeek and other Future Publishing Limited brands as detailed here.

Reset your password

A link has been emailed to you - check your inbox.


Don't have an account? Click here to register

Recommended

Britain’s ten most-hated shares – w/e 1 July
Stocks and shares

Britain’s ten most-hated shares – w/e 1 July

Rupert Hargreaves looks at Britain's ten most-hated shares, and what short-sellers are looking at now.
4 Jul 2022
Britain’s most-bought shares w/e 1 July
Stocks and shares

Britain’s most-bought shares w/e 1 July

A look at Britain’s most-bought shares in the week ending 1 July, providing an insight into how investors are thinking and where opportunities may lie…
4 Jul 2022
M&G offers a solid 10.1% yield – but future growth is uncertain
Share tips

M&G offers a solid 10.1% yield – but future growth is uncertain

Financial services group M&G has one of the highest dividend yields in the FTSE 100. But it’s a complicated company, and a tough one to analyse, says …
4 Jul 2022
We’re doing well on pensions – but we still need to do better
Pensions

We’re doing well on pensions – but we still need to do better

Pensions auto-enrolment has vastly increased the number of people in the UK with retirement savings. But we’re still not engaged enough, says Merryn S…
4 Jul 2022

Most Popular

Ray Dalio’s shrewd $10bn bet on the collapse of European stocks
European stockmarkets

Ray Dalio’s shrewd $10bn bet on the collapse of European stocks

Ray Dalio’s Bridgewater hedge fund is putting its money on a collapse in European stocks. It’s likely to pay off, says Matthew Lynn.
3 Jul 2022
UK house prices are definitely cooling off – but are they heading for a fall?
House prices

UK house prices are definitely cooling off – but are they heading for a fall?

UK house prices hit a fresh high in June, but as interest rates start to rise, the market is cooling John Stepek assesses just how much of an effect h…
30 Jun 2022
Persimmon yields 12.3%, but can you trust the company to deliver?
Share tips

Persimmon yields 12.3%, but can you trust the company to deliver?

With a dividend yield of 12.3%, Persimmon looks like a highly attractive prospect for income investors. But that sort of yield can also indicate compa…
1 Jul 2022
Skip to ContentSkip to Footer